tiprankstipranks
Trending News
More News >
American Healthcare REIT, Inc. (AHR)
NYSE:AHR
US Market

American Healthcare REIT, Inc. (AHR) AI Stock Analysis

Compare
161 Followers

Top Page

AH

American Healthcare REIT, Inc.

(NYSE:AHR)

Rating:68Neutral
Price Target:
$39.00
▲(5.21%Upside)
The overall stock score of 68 reflects the company's strong financial performance marked by revenue growth and improved operational efficiency, despite ongoing profitability challenges. Technical indicators support a positive outlook with strong momentum. Although the valuation is hampered by a negative P/E ratio, the attractive dividend yield and positive corporate events contribute to investor appeal.
Positive Factors
Acquisitions
The $300 million acquisition pipeline of deals already awarded to AHR could drive additional growth.
Financial Performance
The company continues to generate eye-popping same-store NOI of 15.1% in the quarter given the sector strength and their efficient operators.
Guidance
Guidance now suggests approximately 20% FFO growth driven by 11% organic growth.
Negative Factors
Earnings Estimates
Lowering FFO Estimates due to recent property dispositions and equity offering.
Earnings Report
The income statement published in the earnings press release is missing values for Loss from unconsolidated entities.
Growth Projections
Lower growth is expected going into 2025.

American Healthcare REIT, Inc. (AHR) vs. SPDR S&P 500 ETF (SPY)

American Healthcare REIT, Inc. Business Overview & Revenue Model

Company DescriptionAmerican Healthcare REIT, Inc. (AHR) is a real estate investment trust (REIT) focused on owning and managing a diverse portfolio of healthcare-related properties across the United States. The company primarily invests in medical office buildings, senior housing, skilled nursing facilities, hospitals, and other healthcare facilities. AHR aims to provide stable and growing income to its investors through strategic acquisitions and effective property management in the healthcare sector.
How the Company Makes MoneyAmerican Healthcare REIT, Inc. generates revenue primarily through leasing its healthcare properties to healthcare providers and operators. The company earns rental income from long-term leases, which are often structured with inflation escalators or rent increases over time. AHR also benefits from property appreciation and capital gains by strategically acquiring and disposing of assets within its portfolio. Additionally, the company may form joint ventures or partnerships with healthcare operators to enhance property management and operational efficiency, further contributing to its earnings.

American Healthcare REIT, Inc. Earnings Call Summary

Earnings Call Date:May 08, 2025
(Q4-2024)
|
% Change Since: 15.88%|
Next Earnings Date:Aug 07, 2025
Earnings Call Sentiment Positive
The earnings call presented a strong performance for American Healthcare REIT in 2024, with significant growth in key segments such as Trilogy and a substantial reduction in leverage. The company has a positive outlook for 2025, with expectations for continued growth. However, challenges remain in the outpatient medical segment, and there are concerns regarding potential policy changes in healthcare. Despite these challenges, the robust performance and strategic investments position the company well for the coming year.
Q4-2024 Updates
Positive Updates
Strong Same-Store NOI Growth
Total portfolio same-store NOI grew 21.6% year over year in the fourth quarter, with full year 2024 same-store NOI growth at 17.7% compared to 2023.
Trilogy Segment Performance
Trilogy segment's same-store NOI grew by 28% year over year in Q4 2024, and 23.8% for the full year. This segment is noted for its robust health outcomes and financial results.
Significant Reduction in Leverage
Net debt to adjusted EBITDA decreased from 8.5 times at the end of 2023 to 4.3 times at the end of 2024, enhancing financial flexibility.
Successful Capital Allocation Strategy
Invested over $650 million in external growth in managed long-term care segments in 2024 and announced new investments for 2025, including two new shop assets and several Trilogy development projects.
Positive Outlook for 2025
Guidance for 2025 includes 7% to 10% same-store NOI growth and $1.56 to $1.60 NFFO per share, anticipating double-digit NFFO per share growth.
Negative Updates
Outpatient Medical Segment Challenges
Guidance for outpatient medical reflects headwinds from expected tenant move-outs, with predicted same-store NOI growth declines of 1.5% to 0.5%.
Q1 2025 Sequential Headwinds
Expectations of modest sequential headwinds to Trilogy NOI in Q1 2025 due to compensation-related expenses and seasonality, such as fewer days in Q1.
Potential Policy Changes Impact
Concerns about potential policy changes in the healthcare sector, primarily related to Medicaid, which could affect future operations and reimbursement rates.
Company Guidance
During the fourth quarter 2024 earnings call, American Healthcare REIT provided guidance for 2025, highlighting anticipated double-digit growth in key financial metrics. The company expects same-store NOI growth between 7% and 10%, with Trilogy and shop segments expected to lead with 10% to 12% and 18% to 22% growth, respectively. They project normalized funds from operations (NFFO) per share to increase to $1.56 to $1.60, reflecting strong operational performance and strategic investments. In 2024, American Healthcare REIT achieved a 17.7% growth in same-store NOI and reduced net debt to adjusted EBITDA from 8.5 times to 4.3 times. The company plans to continue pursuing accretive investments, having allocated over $650 million in 2024 to external growth initiatives, including Trilogy developments, and aims to leverage favorable market conditions and capital structure to capture future opportunities.

American Healthcare REIT, Inc. Financial Statement Overview

Summary
American Healthcare REIT, Inc. demonstrates robust revenue growth and improved operational efficiency. Despite improvements in cash flow and debt reduction, the company struggles with maintaining profitability, as evidenced by recurring net losses. The balance sheet shows a strong equity position but indicates potential risks associated with asset leverage.
Income Statement
65
Positive
American Healthcare REIT, Inc. shows a strong revenue growth trajectory but suffers from negative net income, impacting profitability metrics. Gross profit margins have improved significantly over the years, indicating operational efficiency, yet net profit margins remain negative due to consistent net losses.
Balance Sheet
72
Positive
The company's balance sheet reflects stable equity growth and a substantial reduction in total debt, leading to a healthy debt-to-equity ratio of 0.0 in the latest fiscal year. However, the company's assets are heavily leveraged against equity, suggesting potential risk if asset values fluctuate.
Cash Flow
68
Positive
Cash flows have shown improvement with positive free cash flow growth and a strong operating cash flow to net income ratio. However, fluctuations in capital expenditures and financing activities indicate potential volatility in cash flow management.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue2.11B2.07B1.86B1.62B1.27B1.19B
Gross Profit847.83M416.77M356.83M335.97M235.11M195.39M
EBITDA237.96M315.48M324.26M233.76M186.00M206.71M
Net Income-40.72M-37.81M-71.47M-81.30M-47.79M2.16M
Balance Sheet
Total Assets4.46B4.49B4.58B4.79B4.58B3.23B
Cash, Cash Equivalents and Short-Term Investments86.06M76.70M43.45M65.05M81.60M152.19M
Total Debt0.001.87B3.02B3.11B2.65B1.88B
Total Liabilities2.16B2.18B3.12B3.14B2.75B2.16B
Stockholders Equity2.26B2.26B1.27B1.40B1.58B866.11M
Cash Flow
Free Cash Flow170.60M84.15M-1.26M76.25M-61.78M90.85M
Operating Cash Flow242.66M176.09M98.53M147.77M17.91M219.16M
Investing Cash Flow-36.29M-8.73M9.40M-118.58M-138.65M-147.94M
Financing Cash Flow-179.71M-134.74M-129.06M-42.92M94.11M-8.81M

American Healthcare REIT, Inc. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price37.07
Price Trends
50DMA
34.30
Positive
100DMA
31.61
Positive
200DMA
29.07
Positive
Market Momentum
MACD
0.68
Negative
RSI
67.58
Neutral
STOCH
70.12
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AHR, the sentiment is Positive. The current price of 37.07 is above the 20-day moving average (MA) of 35.70, above the 50-day MA of 34.30, and above the 200-day MA of 29.07, indicating a bullish trend. The MACD of 0.68 indicates Negative momentum. The RSI at 67.58 is Neutral, neither overbought nor oversold. The STOCH value of 70.12 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AHR.

American Healthcare REIT, Inc. Risk Analysis

American Healthcare REIT, Inc. disclosed 77 risk factors in its most recent earnings report. American Healthcare REIT, Inc. reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

American Healthcare REIT, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (57)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
$5.98B34.007.02%4.29%43.27%80.97%
77
Outperform
$4.43B31.515.15%6.45%7.81%179.16%
NHNHI
76
Outperform
$3.31B22.4710.56%5.08%7.44%4.23%
AHAHR
68
Neutral
$5.99B-1.93%2.70%11.30%
HRHR
59
Neutral
$5.59B-6.83%7.79%-7.26%18.45%
57
Neutral
$5.79B25.71-31.22%5.58%10.88%-29.73%
MPMPW
52
Neutral
$2.63B-28.86%7.31%19.56%-12.73%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AHR
American Healthcare REIT, Inc.
37.07
22.10
147.63%
NHI
National Health Investors
70.80
5.20
7.93%
SBRA
Sabra Healthcare REIT
18.62
4.35
30.48%
MPW
Medical Properties
4.38
0.52
13.47%
HR
Healthcare Realty Trust
15.92
0.16
1.02%
CTRE
CareTrust REIT
31.20
6.38
25.71%

American Healthcare REIT, Inc. Corporate Events

Shareholder MeetingsBusiness Operations and Strategy
American Healthcare REIT Holds Annual Stockholders Meeting
Neutral
Jun 26, 2025

On June 25, 2025, American Healthcare REIT, Inc. held its Annual Meeting of Stockholders where four key proposals were voted upon. The stockholders elected nine directors for a one-year term, ratified Deloitte & Touche as the independent accounting firm for 2025, approved executive compensation for 2024 on an advisory basis, and approved the 2025 Manager Equity Plan. These decisions reflect the company’s ongoing governance and strategic planning efforts, potentially impacting its operational and financial management in the coming year.

The most recent analyst rating on (AHR) stock is a Buy with a $18.00 price target. To see the full list of analyst forecasts on American Healthcare REIT, Inc. stock, see the AHR Stock Forecast page.

Dividends
American Healthcare REIT Announces Quarterly Distribution
Positive
Jun 20, 2025

On June 20, 2025, American Healthcare REIT, Inc. announced a quarterly distribution of $0.25 per share for the second quarter of 2025, payable on or about July 18, 2025, to shareholders of record as of June 30, 2025. This distribution reflects an annualized rate of $1.00 per share and underscores the company’s commitment to providing returns to its investors, potentially enhancing its attractiveness in the real estate investment sector.

The most recent analyst rating on (AHR) stock is a Buy with a $18.00 price target. To see the full list of analyst forecasts on American Healthcare REIT, Inc. stock, see the AHR Stock Forecast page.

Business Operations and StrategyFinancial Disclosures
American Healthcare REIT Reports Q1 2025 Financial Results
Neutral
May 8, 2025

On May 8, 2025, American Healthcare REIT, Inc. announced its first quarter 2025 results, reporting a GAAP net loss attributable to controlling interest of $6.8 million and a GAAP net loss per diluted share of $0.04. Despite this, the company achieved a 15.1% growth in Same-Store Net Operating Income (NOI) compared to the previous year, driven by strong performance in its senior housing operating properties and integrated senior health campuses. The company also increased its full-year 2025 guidance, reflecting improved expectations for NOI growth and earnings, supported by successful capital markets activity and strategic asset transactions. The company remains focused on leveraging demand for long-term care and pursuing new growth opportunities.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 21, 2025